AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today named Brian Blakey, Pharm.D. to the newly created position of Vice President of Marketing. Dr. Blakey will report directly to Mark P. Colonnese, AtheroGenics' Executive Vice President, Commercial Operations.
